Lauryn Christiansen

Senior Manager, Translational Biomarkers, Severe Genetic Disease Research @Bluebird Bio

Boston, MA, US

Led the operational strategy of the Biomarker Clinical Assay Development (bCAD) team of 3-8 full-time employees, performing exploratory clinical assays to characterize safety and efficacy for clinical trials in Sickle Cell Disease (lovocel/Lyfgenia), Thalassemia (beticel/Zynteglo), and ALD (elicel/Skysona).• Authored regulatory protocols and reports; reviewed clinical protocols and central laboratory manuals; collaborated on data transfer agreements and clinical data cuts for submission-readiness.• Led assay development and troubleshooting to support safety event investigations and clinical decision-making.• Managed clinical sample inventory and exploratory biomarker testing processes for over 200 trial participant samples annually, improving compliance and operational efficiency.• Communicated with internal and external stakeholders (CROs, clinical sites, vendors, and collaborators) regarding subject samples and protocols to ensure timely collection and delivery.• Facilitated successful lab relocation, overseeing equipment qualification and audit inspection, minimizing downtime.• Collaborated cross functionally with Data Science, IT, Facilities, Finance, Quality, Regulatory, Clinical Operations and Data Management teams.• Financial management for translational biomarkers team and optimized budget and personnel.

Clark University

Bachelor's degree, Biochemistry and Molecular Biology